The Division of Cancer Treatment and Diagnosis (DCTD) is spearheading innovative cancer research and playing a pivotal role in shaping future cancer treatment and diagnosis. DCTD utilizes a variety of programs and clinical trials to redefine our approach to cancer, striving towards a future where this disease is less intimidating. The main focus of DCTD's work is the creation of novel diagnostics and treatments, from drug discovery to final-stage clinical trials, and enhancing the NCI-60 Human Tumor Cell Lines Screen's potency. Their work isn't solely confined to scientific advancements; they also work to transform these breakthroughs into practical applications that make a significant impact on lives. Recent triumphs encompass the potential for rectal cancer patients to avoid pre-surgery radiation and promising therapy results for aggressive acute lymphoblastic leukemia in infants. DCTD also supports collaboration and knowledge exchange through initiatives like ComboMATCH, intensifying the personalized cancer care scope.
Full article here: https://medium.com/@lawsuithelpdesk/unveiling-the-future-of-cancer-diagnosis-and-treatment-the-groundbreaking-work-of-dctd-9a13cfd87b11